# Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer

> **NCT05332483** · PHASE1 · TERMINATED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 5 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Megestrol Acetate

## Key facts

- **NCT ID:** NCT05332483
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-07-05
- **Primary completion:** 2023-10-12
- **Final completion:** 2023-10-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2023-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05332483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05332483, "Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05332483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*